Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Join clinical trials for free access Clinical trials provide free GLP-1 medications with professional medical oversight
Ince, S
CrossRef Liver cirrhosis in metabolic dysfunction-associated steatohepatitis Donghyun Ko, Do Han Kim, Pojsakorn Danpanichkul, Masahito Nakano, Chitchai Rattananukrom, Karn Wijarnpreecha, Cheng Han Ng, Mark D Muthiah Gastroenterology Report .2025;[Epub] CrossRef From liver to limb: Exploring the association between fatty liver disease and peripheral artery diseaseA systematic review Vera Ciornolutchii, Abdulrahman Ismaiel, Jennifer Bogdan, StefanLucian Popa, Teodora SurdeaBlaga, Dan L
Overall, the findings suggest potential benefits of GLP-1RA treatment in this high-risk population, although residual confounding and heterogeneity across autoimmune diseases mean the results should not be interpreted as proof of causality
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 23.63
US$ 25.20
US$ 28.10
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)